標(biāo)題: Titlebook: Cannabis Use Disorders; Ivan D. Montoya,Susan R. B. Weiss Book 2019 Springer Nature Switzerland AG 2019 Etiology of Cannabis Use Disorder. [打印本頁] 作者: 一再 時間: 2025-3-21 17:11
書目名稱Cannabis Use Disorders影響因子(影響力)
書目名稱Cannabis Use Disorders影響因子(影響力)學(xué)科排名
書目名稱Cannabis Use Disorders網(wǎng)絡(luò)公開度
書目名稱Cannabis Use Disorders網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cannabis Use Disorders被引頻次
書目名稱Cannabis Use Disorders被引頻次學(xué)科排名
書目名稱Cannabis Use Disorders年度引用
書目名稱Cannabis Use Disorders年度引用學(xué)科排名
書目名稱Cannabis Use Disorders讀者反饋
書目名稱Cannabis Use Disorders讀者反饋學(xué)科排名
作者: 翅膀拍動 時間: 2025-3-21 21:42
Epidemiology of Cannabis Use Disorder, a greater understanding of who may be at increased or decreased risk of cannabis-related problems and why, with the ultimate goal of helping to help guide interventions to reduce public health burden. This chapter describes the goals of epidemiology, defines what constitutes cannabis use and disord作者: CLASP 時間: 2025-3-22 01:31 作者: guardianship 時間: 2025-3-22 05:08
The Endogenous Cannabinoid System: A Cadre of Potential Therapeutic Targets,only recently gained general acceptance. The systematic study of the biological systems underlying the effects of these drugs has contributed to a tremendous wealth of knowledge in understanding not only the molecular basis of the pharmacological effects of cannabis but also led to the identificatio作者: 無可非議 時間: 2025-3-22 09:00 作者: 憤憤不平 時間: 2025-3-22 16:04
The Molecular Basis of Cannabinoid Activity: Application to Therapeutics Design and Discovery for Cnts and the biochemical processes they participate in was stimulated some 25?years ago by seminal evidence that Δ.-tetrahydrocannabinol (Δ.-THC), the principal psychoactive component of . sp., exerts its psychotropic effects mainly through engaging and activating a class-A (rhodopsin-like) G protein作者: 憤憤不平 時間: 2025-3-22 19:44 作者: Corroborate 時間: 2025-3-22 22:44
Animal Models of Cannabis Use Disorder, CUD have difficulty discontinuing cannabis use, and there are currently no approved medications for the treatment of CUD. Preclinical research in animals has been invaluable in uncovering neurobiological underpinnings of many neuropsychiatric disorders, as well as for the development of safe and ef作者: Hectic 時間: 2025-3-23 02:44 作者: 性滿足 時間: 2025-3-23 08:58 作者: 一再遛 時間: 2025-3-23 09:52
Cannabis Withdrawal,oms. The onset of these symptoms closely follows cessation, mostly persists for 2–3?weeks, and can produce clinically significant distress that contributes to the maintenance of frequent cannabis use. Cannabis withdrawal develops as a result of neurobiological changes in the endogenous cannabinoid s作者: 神刊 時間: 2025-3-23 16:42
Cannabis and Cannabinoid Intoxication and Toxicity,artment visits due to both unintentional and abuse-related exposures. Toxicity as a consequence of synthetic cannabinoid use (i.e., Spice, K2) has also become an apparent clinical issue with sometimes severe adverse consequences. This chapter will describe the prevalence of over-intoxication, or tox作者: 食料 時間: 2025-3-23 19:08
Psychiatric Comorbidity of Cannabis Use Disorder,findings of English-language epidemiological studies reporting current (past-year) comorbidity and of controlled clinical trials of treatment in which the majority of participants had diagnosed CUD and a specific comorbid disorder..Results: There is substantial CUD comorbidity among community-dwelli作者: Decibel 時間: 2025-3-24 01:35 作者: Fsh238 時間: 2025-3-24 03:52
Medical Consequences of Cannabis Use,d other variables, cannabis use can be associated with a broad spectrum of medical consequences, the range of which mirrors the physiological ubiquity and versatility of the endocannabinoid system. Importantly, the adverse consequences of cannabis use can progress to become overt clinical conditions作者: 有惡意 時間: 2025-3-24 10:02 作者: 發(fā)出眩目光芒 時間: 2025-3-24 13:37 作者: 一致性 時間: 2025-3-24 18:24 作者: Cumulus 時間: 2025-3-24 21:45 作者: Permanent 時間: 2025-3-25 00:14
Book 2019D). Unlike any other current medical text, this volume focuses on the scientific aspects of CUDs and provides a resource for researchers, physicians and other health care providers who treat patients suffering from the disorder or its consequences. It begins by establishing the landscape of the diso作者: Diverticulitis 時間: 2025-3-25 03:42
Christophe Dooms,Christophe Derooseral components of a comprehensive picture of CUD, as well as a necessary and timely discussion of cannabis policy and how the continuing evolution of cannabis legislation across US states could impact cannabis use and disorder, and how we treat them, moving forward.作者: 反叛者 時間: 2025-3-25 09:43 作者: Clumsy 時間: 2025-3-25 15:04 作者: STELL 時間: 2025-3-25 17:17
Epidemiology of Cannabis Use Disorder,ral components of a comprehensive picture of CUD, as well as a necessary and timely discussion of cannabis policy and how the continuing evolution of cannabis legislation across US states could impact cannabis use and disorder, and how we treat them, moving forward.作者: maverick 時間: 2025-3-25 20:11 作者: Pantry 時間: 2025-3-26 01:17 作者: 用肘 時間: 2025-3-26 07:00
Medical Consequences of Cannabis Use,, independently of the development of a cannabis use disorder. The purpose of this chapter is to present an updated overview of these adverse health effects of cannabis use and the implications of our current understanding vis-á-vis public health and research agendas moving forward.作者: Abutment 時間: 2025-3-26 09:39 作者: 生來 時間: 2025-3-26 13:27 作者: 玷污 時間: 2025-3-26 18:02 作者: 愛得痛了 時間: 2025-3-26 22:24
,Translation of CUD Therapeutics from Drug Discovery to the?Clinic,l discuss experimental approaches used to date to treat cannabis use disorder (CUD) as well as a brief history of cannabinoid pharmacology (and physiology). It is hoped that these factors may clarify where we have come from, why it has taken so long, and the direction forward.作者: Precursor 時間: 2025-3-27 04:25 作者: Hectic 時間: 2025-3-27 08:03 作者: Maximize 時間: 2025-3-27 11:51 作者: 預(yù)防注射 時間: 2025-3-27 15:38 作者: Anguish 時間: 2025-3-27 21:09
Introduction to Cannabis Use Disorders, endocannabinoid system, the effects of cannabinoids, and the brain mechanisms of CUD. These new discoveries are allowing the identification of novel pharmacological targets and medications that may affect the endocannabinoid system and may be useful for the treatment of CUD and other medical condit作者: 忙碌 時間: 2025-3-28 01:08
Genetic Aspects of Cannabis Use Disorder,e confirmed in further studies. Thus, the genetics of cannabis use and CUD is in its infancy. For these reasons, it may be time to reflect on current methods and revise our models to integrate other approaches to phenotyping, leading to more precise gene candidate identification and an understanding作者: BIBLE 時間: 2025-3-28 04:12 作者: palliate 時間: 2025-3-28 06:39 作者: 珠寶 時間: 2025-3-28 14:30 作者: 壓碎 時間: 2025-3-28 15:12
Cannabis and Cannabinoid Intoxication and Toxicity,ents reported in the literature will be summarized. As cannabis availability grows and strength of products increases, clinician awareness of the signs and symptoms of cannabis toxicity is critical for undertaking the optimal course of patient treatment. Additionally, knowledge of the risks associat作者: Perennial長期的 時間: 2025-3-28 20:29 作者: extemporaneous 時間: 2025-3-29 01:21 作者: 吸引人的花招 時間: 2025-3-29 06:49 作者: euphoria 時間: 2025-3-29 08:58 作者: 關(guān)心 時間: 2025-3-29 12:40
,Cannabis Use Disorder as a?Developmental Disorder,evidence suggests promising pharmacological adjuncts for the treatment of adolescent CUD, however. Preliminary data examining these pharmacological treatments suggests that effective treatments for adults may not be appropriate or effective for adolescents and vice versa, though further research is 作者: Customary 時間: 2025-3-29 16:52 作者: Constrain 時間: 2025-3-29 21:11 作者: RAFF 時間: 2025-3-30 01:36 作者: 大喘氣 時間: 2025-3-30 05:20 作者: –吃 時間: 2025-3-30 11:26 作者: 軟弱 時間: 2025-3-30 15:18
Strategies in ALK Rearranged NSCLC Patientsor 2 (CB2R)] and insight into the key physiological roles of the enzymes monoacylglycerol lipase (MGL) and fatty acid amide hydrolase (FAAH) in terminating, respectively, 2-AG and AEA signaling functions. The importance of the endocannabinoid system in regulating many biological processes has stimul作者: 打折 時間: 2025-3-30 18:31 作者: Demonstrate 時間: 2025-3-30 22:33
Talimogene Laherparepvec (T-VEC)ents reported in the literature will be summarized. As cannabis availability grows and strength of products increases, clinician awareness of the signs and symptoms of cannabis toxicity is critical for undertaking the optimal course of patient treatment. Additionally, knowledge of the risks associat作者: ECG769 時間: 2025-3-31 01:55 作者: 恃強(qiáng)凌弱的人 時間: 2025-3-31 05:01
Hanna Kose?a-Paterczyk,Piotr Rutkowskiabinoids are associated with psychosis that manifests soon after exposure, typically lasts only for the duration of intoxication (hours) and that typically does not involve significant clinical intervention. Cannabinoids are also associated with psychosis that manifests soon after exposure but lasts作者: Interlocking 時間: 2025-3-31 12:39
Licia Rivoltini,Agata Cova,Paola SquarcinaEarly evidence suggests that adverse somatic and psychiatric outcomes associated with the use of SCs may be more prevalent and more severe than those arising from cannabis use. The aim of the current chapter is to review the available data regarding the effects and consequences of SC use in humans. 作者: TRACE 時間: 2025-3-31 14:58
Molecular Landscape of Skin Carcinomascrease in marijuana use by pregnant women, the availability of cannabis with higher THC concentrations, and the introduction and escalating use of synthetic cannabinoids create an urgent need to determine the effects of the amplified fetal THC exposure. The risk of neurodevelopmental problems in THC作者: 擦掉 時間: 2025-3-31 19:19 作者: 你敢命令 時間: 2025-4-1 00:59
https://doi.org/10.1007/978-94-007-1303-1lab, safety concerns and withdrawal of its use from the US market preclude further investigation of this agent. However, development of antagonists with different properties may have clinical utility, though they are in the earliest stages of preclinical investigation.作者: tangle 時間: 2025-4-1 03:28
Book 2019utting-edge diagnostic and biological topics, including genetics, medicalconsequences, and clinical manifestations. The text also covers the challenges and risks presented by external factors, including social repercussions, protective factors, psychiatric comorbidities, withdrawal, and treatment se作者: 小臼 時間: 2025-4-1 09:19 作者: 獨(dú)白 時間: 2025-4-1 11:19
Christophe Dooms,Christophe Deroose a greater understanding of who may be at increased or decreased risk of cannabis-related problems and why, with the ultimate goal of helping to help guide interventions to reduce public health burden. This chapter describes the goals of epidemiology, defines what constitutes cannabis use and disord作者: 讓你明白 時間: 2025-4-1 17:49
New Therapeutic Strategies in Lung Cancers management. The areas of genetics and epigenetics represent promising avenues of research to help respond to this demand. Twin studies have shown that CUD has 50–70% heritability rate, likely involving multiple genes whose expression varies according to an individual’s environment. Initial hypothes作者: 惰性女人 時間: 2025-4-1 19:59
Minimally Invasive Surgery for Early NSCLConly recently gained general acceptance. The systematic study of the biological systems underlying the effects of these drugs has contributed to a tremendous wealth of knowledge in understanding not only the molecular basis of the pharmacological effects of cannabis but also led to the identificatio作者: 不能平靜 時間: 2025-4-2 00:02
New Therapeutic Strategies in Lung Cancers impact, to date no pharmacological treatment has been approved for the clinical management of cannabis dependence..Cannabidiol (CBD), one of the main compounds—together with Δ.-THC—present in the plant ., has been reported to possess anxiolytic, antidepressant, and antipsychotic-like effects and ne作者: PANEL 時間: 2025-4-2 03:38
Strategies in ALK Rearranged NSCLC Patientsnts and the biochemical processes they participate in was stimulated some 25?years ago by seminal evidence that Δ.-tetrahydrocannabinol (Δ.-THC), the principal psychoactive component of . sp., exerts its psychotropic effects mainly through engaging and activating a class-A (rhodopsin-like) G protein作者: Autobiography 時間: 2025-4-2 09:38
Manolo D’Arcangelo MD,Fred R. Hirsch MD, PhDg up to the point that FDA permits “first-in-human” testing. It is intended that this outline will provide insight into the different skill sets and ways of thinking and working that are needed to bring a new medication to the clinic. The purpose is not only to provide basic scientists with a view f作者: 無可非議 時間: 2025-4-2 11:22 作者: 我要威脅 時間: 2025-4-2 18:30 作者: 翻動 時間: 2025-4-2 20:00
Theresa C. Barnes,Robert J. Moots in a substantial number of individuals. CUD manifests in similar phenomena and consequences as other substance use disorders. For example, both adults and youth with CUD report cannabis-associated problems that include inability to cut down or quit, withdrawal symptoms when they discontinue use, wo
